CASE STUDY: Eczema and a Switch from Dupixent®
Eczema can be stubborn to treat if you’re not addressing the root cause. Here’s a case study of one of our eczema patients who tried...
Learn more about the effectiveness and side effects of today’s prescription drugs for common skin conditions, and possible alternatives.
We Look at Ebglyss® for Eczema
In September of 2024, the FDA approved Ebglyss™ (lebrikizumab-lbkz manufactured by Eli Lily and Company) as a prescription treatment for moderate to severe eczema (atopic...
We Look at Zoryve® for Eczema and Psoriasis
In July of 2024, the FDA approved Zoryve® cream (roflumilast) for the treatment of mild to moderate eczema in adults and children ages 6 and...
We Look at Tremfya® for Psoriasis
Tremfya® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis, and/or psoriatic arthritis. It contains the active drug guselkumab and...
Psoriasis? We Look at Taltz®
Taltz® (Ixekizumab) is an injectable medicine used to treat those 6 years of age and older with moderate to severe plaque psoriasis. It is a...
We Take A Look at Opzelura (TM)
OpzeluraTM is a relatively new medication, receiving FDA approval in 2021 as the first topical treatment of its kind for atopic dermatitis (eczema). It is...
We Look at New Psoriasis Medication – SOTYKTU®
The FDA approved the new prescription treatment for Psoriasis, Sotyktu®, in September of 2022. Produced by Bristol Meyers Squibb, Sotyktu® is an oral medication, taken...
FAQ: Switching from Skyrizi® to Herbal Medicine
A new prescription medication Skyrizi® was approved for patients with plaque psoriasis in April 2019. However, some patients may experience negative side effects. Others may...
We Look at Rinvoq®, Cibinqo®, and Adbry®
While it’s encouraging that mainstream medicine is hard at work researching and creating new medications to treat eczema, we want our readers to stay aware...
- 1
- 2